1.Study of regional cerebral blood flow in the patients with acute intracerebral hemorrhage
Hongyan DING ; Qiang DONG ; Langfeng SHI
Journal of Clinical Neurology 1988;0(02):-
Objective To study the dynamic changes of regional cerebral blood flow(rCBF) in hematoma, perihematoma and their enantiomorph in the contralateral hemisphere in the patients with acute intracerebral hemorrhage(ICH). Methods 15 patients of acute basal ganglia hemorrhage were divided into different groups according to the Chinese Stroke Scales, 10 patients were minor, the other 5 patients were moderate. 99mtechnetium-ethyl -cysteinate-dimer single-photon emission CT ( 99mTc-ECD SPECT) were performed within 3 days after onset of the disease and re-examined at 16 days. The method of region of interesting (ROI) was used to measure the uptake counts in the core of hematoma, frontal or parietal region around the lesion, the center of cerebellum and their enantiomorphs in the contralateral hemisphere, respectively,and to calculate the ratio of uptake counts.Results The uptake counts showed difference in the second time exam between perilesion and its enantiomorph in minor patients ( P0.05). The uptake counts of contralateral cerebellum were less than those of hemorrhage lateral cerebellum ( P
2.Cerebral ischemia induces astrocytes to express granulocyte colony stimulating factor and glial cell fine-derived neurotrophic factor
Langfeng SHI ; Chuanzhen Lü ; Baoguo XIAO
Chinese Journal of Neurology 2009;42(10):694-698
Objective To explore the neuroprotective mechanisms of granulocyte colony stimulating factor (G-CSF) in ischemic brain injury. Methods Brain tissues were taken out from MCAO and sham operated Sprague-Dawley rats 7 days after operation. The expression of G-CSFR, GDNF, MAP2 and GFAP was measured by using immunofluorescence co-staining. Results The expression of G-CSFR and GDNF were widely distributed in the neurons in normal brain tissues, not in the astrocytes. However, in ischemic peripheral zone, part of G-CSFR and GDNF positive cells merged with GFAP positive cells, in normal brain tissues, most G-CSFR positive cells were co-expressed with GDNF. Conclusion Cerebral ischemia induces astrocytes to express G-CSFR and GDNF, suggesting that endogenous neuroprotection by cerebral ischemia may be related with the expression and production of G-CSFR and GDNF in astrocytes in ischemic peripheral zone.
3.Clinical and magnetic resonance imaging analysis of 13 patients with hypertrophic cranial pachymeningitis
Junjun SHEN ; Changming GENG ; Wenhua ZHU ; Langfeng SHI ; Xiang HAN ; Qiang DONG
Chinese Journal of Neurology 2014;47(10):695-700
Objective To investigate clinical presentations,laboratory examinations,magnetic resonance imaging (MRI) appearances and treatment of hypertrophic cranial pachymeningitis (HCP).Methods The clinical data of 13 patients with HCP receiving comprehensive therapy in Huashan Hospital from January 2007 to January 2013 were analyzed retrospectively.Results The onset of HCP was mostly chronic with an average duration of 26.7 months.The main clinical manifestations of the 13 patients were chronic headaches (12/13) and cranial nerve paralysis (12/13).Inflammation markers and cerebro-spinal fluid (CSF) protein levels increased in patients with HCP and gradually became normal after the treatment.The MRI demonstrated local or diffused thickened dura located in tentorium (10/13),falx cerebrum (5/13),frontal lobe (4/13),temporal lobe (7/13) and parietal lobe (4/13).The signal intensity was isointense on T1-weighted MR images and hypointense on T2-weighted MR images.Enhanced MR images showed conspicuous enhancement of the dural edges.Corticosteroid therapy improved the clinical symptoms in 12 of 13 patients.Conclusions HCP typically causes headache and paralysis of multiple cranial nerves.Enhanced MRI shows characteristic manifestations.At present corticosteroid therapy is the treatment of choice followed by immunosuppressive agent and radiotherapy.
4.Effect of Shenxiong glucose injection on platelet reactivity during aspirin treatment in patients with acute ischemic stroke
Jing CHEN ; Zhong ZHAO ; Qi FANG ; Langfeng SHI ; Gang LI ; Xuesheng LU ; Zhenli GUO ; Qing HU ; Yong CHENG ; Xuejun TANG ; Chunfeng LIU
International Journal of Cerebrovascular Diseases 2018;26(12):892-896
Objective To investigate the effect of Shenxiong glucose injection on platelet reactivity during aspirin treatment in patients with acute ischemic stroke.Methods A total of 263 patients with acute ischemic stroke admitted to 12 hospitals from January 2014 to December 2016 were enrolled prospectively.They were randomly divided into aspirin group and aspirin + Shenxiong glucose injection group.The changes of platelet maximum aggregation rate induced by 4 platelet aggregating agents (arachidonic acid,adenosine diphosphate,collagen and platelet activating factor) were detected before and after the treatment.Results There were no significant differences in the demographic data and baseline clinical characteristics between the aspirin group (n =132) and the Shenxiong glucose injection + aspirin group (n =131).At baseline,the maximum aggregation rate of platelet induced by arachidonic acid and platelet activating factor in Shenxiong glucose injection + aspirin group was significantly higher than that in the aspirin group (all P <0.05).On the 6th day after treatment,the maximum aggregation rate of platelets induced by the 4 aggregating agents in the Shenxiong glucose injection + aspirin group was significantly lower than that in the aspirin group (all P < 0.001).Conclusion Shenxiong glucose injection had a significant inhibitory effect on platelet reactivity during aspkin treatment in patients with acute ischemic stroke.